Targeted biomarker testing
HRD testing for PARP therapy
Endometrial cancer profiling
Breast cancer recurrence risk asse..
Integrated DNA, RNA & Protein Pro..
Advanced comprehensive genomic..
Minimal residual disease monitoring
Treatment response monitoring
Hereditary cancer risk assessment
Comprehensive biomarker analys.
An AI-powered clinical workspace
Peer-reviewed research and manuscripts
In-depth technical analyses
Educational content for all audiences Coming Soon
Answers to common questions
Real-world clinical impact stories
Articles and webinars from our team
Latest developments delivered to you
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Official announcements and statements
Media coverage and mentions
Latest news and developments
Events, talks, and participation
Why we do, what we do
Leadership, advisors, and board
Certifications and capabilities
Join our team
Awards and press coverage
